news
09-09-2012, 10:10 PM
Research on a common lung cancer could foretell a type of treatment in which drugs — many of which are in the pipeline already — are chosen to match the genetic mutation in each patient.http://rss.nytimes.com/c/34625/f/642562/s/233d28ef/mf.gif
http://da.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2.img (http://da.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2.htm)http://pi.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2t.img
More... (http://www.nytimes.com/2012/09/10/health/research/for-a-lung-cancer-drug-treatment-may-be-within-reach.html?partner=rss&emc=rss)
http://da.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2.img (http://da.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2.htm)http://pi.feedsportal.com/r/144540234889/u/79/f/642562/c/34625/s/233d28ef/a2t.img
More... (http://www.nytimes.com/2012/09/10/health/research/for-a-lung-cancer-drug-treatment-may-be-within-reach.html?partner=rss&emc=rss)